Nanalysis Scientific (CVE:NSCI) Sets New 1-Year Low – Should You Sell?

Nanalysis Scientific Corp. (CVE:NSCIGet Free Report)’s stock price hit a new 52-week low on Tuesday . The company traded as low as C$0.11 and last traded at C$0.11, with a volume of 154925 shares traded. The stock had previously closed at C$0.12.

Nanalysis Scientific Price Performance

The firm’s 50 day moving average price is C$0.13 and its two-hundred day moving average price is C$0.13. The company has a debt-to-equity ratio of 71.72, a current ratio of 1.42 and a quick ratio of 1.10. The stock has a market cap of C$16.03 million, a PE ratio of -3.83 and a beta of -0.56.

About Nanalysis Scientific

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.

Further Reading

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.